The 11 most innovative medical devices of 2017

Share

4. Boston Scientific: Watchman left atrial appendage closure device

watchman

[Image from WATCHMAN]

Boston Scientific’s Watchman left atrial appendage closure device can potentially reduce the risk of stroke in non-valvular atrial fibrillation (NVAF) patients. It has been proven to be safe and an effective alternative to oral anticoagulants. It also reduces the risk of bleeding with warfarin use. The company says the device is designed to reduce the risk of thromboembolism from the left atrial appendage in patients who have NVAF and who have an increased risk of stroke and systemic embolism.

Next >>

How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.


Register now with the code "TAVR" and save 15% today.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12

Speak Your Mind

*